Dendreon Corporation
(Other OTC/NBB : DNDN)

( )
DNDN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
ABTAbbott Laboratories
MDTMedtronic PLC
ISRGIntuitive Surgical, Inc.
TMOThermo Fisher Scientific Inc.
EWEdwards Lifesciences Corporation
ALGNAlign Technology, Inc.
BSXBoston Scientific Corporation
BDXBecton, Dickinson and Company
SYKStryker Corporation
BAXBaxter International Inc.
DXCMDexCom, Inc.
ZBHZimmer Biomet Holdings, Inc.
TNDMTandem Diabetes Care, Inc.
WATWaters Corporation

Company Profile

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.